Switch to:
More From Other Websites
Performance of Merck’s Diabetes Portfolio in 1Q17 May 24 2017
AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk May 24 2017
The Zacks Analyst Blog Highlights: Oracle, Chubb, AstraZeneca, Estee Lauder and Aflac May 24 2017
Novo Nordisk Diabetes Lead Unscathed Following AstraZeneca Trial May 23 2017
New Research Reports for Oracle, Chubb, AstraZeneca & Others May 23 2017
AstraZeneca Sells Marketing Rights to Seloken in Europe May 23 2017
AstraZeneca PLC (AZN): Strong Industry, Solid Earnings Estimate Revisions May 23 2017
BYDUREON EXSCEL Trial Meets Primary Safety Objective in Type-2 Diabetes Patients at Wide Range of... May 23 2017
AstraZeneca Shares Rise as Investors Shrug Off Mixed Diabetes Results May 23 2017
Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab May 22 2017
Phase III ZONDA Trial for benralizumab Shows Ability to Reduce Oral Steroid Use in Severe Asthma... May 22 2017
Severe asthma drug shows AstraZeneca promise beyond cancer May 22 2017
[$$] AstraZeneca sells Seloken European rights for $300m May 22 2017
AstraZeneca sells ageing beta-blocker to Recordati for $300 mln May 22 2017
Build Your Investing Watch List With Stock Ratings, Buy Zones, Earnings May 18 2017
Big Pharma Stock Astrazeneca Gets Relative Strength Upgrade May 18 2017
Vertex Pharmaceuticals' Shares Pop in Afterhours Trading After FDA Approval while AstraZeneca Sinks... May 18 2017
Did AstraZeneca Rival Just Launch A Potential Blockbuster Drug? May 17 2017
Eli Lilly: Worries Ahead In Patent Fight May 17 2017
[$$] Big pharma hopes rule change will ease China sales pain May 16 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK